The FDA has issued emergency authorizations to 12 antibody tests for the virus. As federal officials gradually begin reopening the country, expanded testing is central to the conversation. Until now, ...
Recently, Pfizer made public a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Subsequently, there has been an increased interest in developing RSV therapies ...
In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Since then, RSV therapies have garnered renewed global attention. However, ...
Researchers used AI to identify an mpox protein that triggers a strong immune response in mouse models. | Drug Discovery And ...
Antibodies, also known as immunoglobulins, are specialized proteins produced by the immune system to identify and neutralize foreign invaders, such as viruses, bacteria, and other pathogens. They are ...
RA patients positive for anti-EBV EA-DR IgG antibodies show higher ACPA levels and increased disease activity, suggesting a ...
Animal Models Show Full Protection Against Omicron Variant Despite Absence of Neutralizing Antibodies, Highlighting Critical Importance of T-cell Immunity for Next-generation COVID-19 Vaccines ATLANTA ...
With the help of artificial intelligence, an international team of researchers has made the first major inroad to date toward a new and more effective way to fight the monkeypox virus (MPXV), which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback